Gustavsson A, Norton N, Fast T, Frolich L, Georges J, Holzapfel D, Kirabali T, Krolak-Salmon P, Rossini PM, Ferretti MT, Lanman L, Chadha AS, van der Flier WM (2023) Global estimates on the number of persons across the Alzheimer’s disease continuum. Alzheimers Dement 19(2):658–670

Article  PubMed  Google Scholar 

Adnan M, Koli S, Mohammad T, Siddiqui AJ, Patel M, Alshammari N, Bardakci F, Elasbali AM, Hassan MI (2022) Searching for novel anaplastic lymphoma kinase inhibitors: structure-guided screening of natural compounds for a tyrosine kinase therapeutic target in cancers. OMICS 26(8):461–470

Article  CAS  PubMed  Google Scholar 

Surguchov A, Emamzadeh FN, Titova M, Surguchev AA (2023) Controversial properties of amyloidogenic proteins and peptides: new data in the COVID era. Biomedicines 11(4):1215

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy MP, LeVine H 3rd (2010) Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis 19(1):311–323

Article  PubMed  PubMed Central  Google Scholar 

d’Errico P, Meyer-Luehmann M (2020) Mechanisms of pathogenic tau and abeta protein spreading in Alzheimer’s disease. Front Aging Neurosci 12:265

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahman MM, Lendel C (2021) Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology. Mol Neurodegener 16(1):59

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prabha S, Choudhury A, Islam A, Thakur SC, Hassan MI (2025) Understanding of Alzheimer’s disease pathophysiology for therapeutic implications of natural products as neuroprotective agents. Ageing Res Rev 102680. https://doi.org/10.1016/j.arr.2025.102680

Prabha S, Sajad M, Hasan GM, Islam A, Hassan MI, Thakur SC (2024) Recent advancement in understanding of Alzheimer’s disease: risk factors, subtypes, and drug targets and potential therapeutics. Ageing Res Rev 102476. https://doi.org/10.1016/j.arr.2024.102476

Simic G, Babic Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milosevic N, Bazadona D, Buee L, de Silva R, Di Giovanni G, Wischik C, Hof PR (2016) Tau protein hyperphosphorylation and aggregation in Alzheimer’s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules 6(1):6

Article  PubMed  PubMed Central  Google Scholar 

Vacchi E, Kaelin-Lang A, Melli G (2020) Tau and alpha synuclein synergistic effect in neurodegenerative diseases: when the periphery is the core. Int J Mol Sci 21(14):5030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Benedetto G, Burgaletto C, Bellanca CM, Munafò A, Bernardini R, Cantarella G (2022) Role of microglia and astrocytes in Alzheimer’s disease: from neuroinflammation to Ca2+ homeostasis dysregulation. Cells 11(17):2728

Article  PubMed  PubMed Central  Google Scholar 

Cai Y, Liu J, Wang B, Sun M, Yang H (2022) Microglia in the neuroinflammatory pathogenesis of Alzheimer’s disease and related therapeutic targets. Front Immunol 13:856376

Article  CAS  PubMed  PubMed Central  Google Scholar 

Havekes R, Heckman PRA, Wams EJ, Stasiukonyte N, Meerlo P, Eisel ULM (2019) Alzheimer’s disease pathogenesis: the role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes. Cell Signal 64:109420

Article  CAS  PubMed  Google Scholar 

Alzheimer's disease facts and figures (2020). Alzheimers Dement. https://doi.org/10.1002/alz.12068

Bruun M, Koikkalainen J, Rhodius-Meester HFM, Baroni M, Gjerum L, van Gils M, Soininen H, Remes AM, Hartikainen P, Waldemar G, Mecocci P, Barkhof F, Pijnenburg Y, van der Flier WM, Hasselbalch SG, Lotjonen J, Frederiksen KS (2019) Detecting frontotemporal dementia syndromes using MRI biomarkers. Neuroimage Clin 22:101711

Article  PubMed  PubMed Central  Google Scholar 

Kumar A, Sidhu J, Lui F, Tsao JW, Doerr C. (2025) Alzheimer disease (Nursing). In: StatPearls. StatPearls Publishing, Treasure Island 

Igarashi KM (2023) Entorhinal cortex dysfunction in Alzheimer’s disease. Trends Neurosci 46(2):124–136

Article  CAS  PubMed  Google Scholar 

McGirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z (2022) Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late-onset neuropsychiatric symptoms. Neurology 98(21):e2132–e2139

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenberg PB, Lyketsos C (2008) Mild cognitive impairment: searching for the prodrome of Alzheimer’s disease. World Psych 7(2):72–78

Article  Google Scholar 

Bukhari SNA (2022) Dietary polyphenols as therapeutic intervention for Alzheimer’s disease: a mechanistic insight. Antioxidants (Basel) 11(3):554

Article  CAS  PubMed  Google Scholar 

Stefaniak O, Dobrzyńska M, Drzymała-Czyż S, Przysławski J (2022) Diet in the prevention of Alzheimer’s disease: current knowledge and future research requirements. Nutrients 14(21):4564

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajaram S, Jones J, Lee GJ (2019) Plant-based dietary patterns, plant foods, and age-related cognitive decline. Adv Nutr 10:S422–S436

Article  PubMed  PubMed Central  Google Scholar 

Figueira I, Menezes R, Macedo D, Costa I, Dos Santos CN (2017) Polyphenols beyond barriers: a glimpse into the brain. Curr Neuropharmacol 15(4):562–594

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shahidi F, Ambigaipalan P (2015) Phenolics and polyphenolics in foods, beverages and spices: antioxidant activity and health effects – a review. J Funct Foods 18:820–897

Article  CAS  Google Scholar 

Caruana M, Cauchi R, Vassallo N (2016) Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease. Front Nutr 3:31

Article  PubMed  PubMed Central  Google Scholar 

Rahman MH, Akter R, Bhattacharya T, Abdel-Daim MM, Alkahtani S, Arafah MW, Al-Johani NS, Alhoshani NM, Alkeraishan N, Alhenaky A, Abd-Elkader OH, El-Seedi HR, Kaushik D, Mittal V (2020) Resveratrol and neuroprotection: impact and its therapeutic potential in Alzheimer’s disease. Front Pharmacol 11:619024

Article  CAS  PubMed  PubMed Central  Google Scholar 

Phan HT, Samarat K, Takamura Y, Azo-Oussou AF, Nakazono Y, Vestergaard MDC (2019) Polyphenols modulate alzheimer’s amyloid beta aggregation in a structure-dependent manner. Nutrients 11(4):756

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kabir ER, Chowdhury NM, Yasmin H, Kabir MT, Akter R, Perveen A, Ashraf GM, Akter S, Rahman MH, Sweilam SH (2023) Unveiling the potential of polyphenols as anti-amyloid molecules in Alzheimer’s disease. Curr Neuropharmacol 21(4):787–807

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi H, Murata M, Kawanishi S, Oikawa S (2020) Polyphenols with anti-amyloid β aggregation show potential risk of toxicity via pro-oxidant properties. Int J Mol Sci 21(10):3561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Q, Kebede MT, Kemeh MM, Islam S, Lee B, Bleck SD, Wurfl LA, Lazo ND (2019) Inhibition of the self-assembly of Aβ and of tau by polyphenols: mechanistic studies. Molecules 24(12):2316

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hussain T, Tan B, Yin Y, Blachier F, Tossou MC, Rahu N (2016) Oxidative stress and inflammation: what polyphenols can do for us? Oxid Med Cell Longev 2016:7432797

Article  PubMed  PubMed Central  Google Scholar 

Yahfoufi N, Alsadi N, Jambi M, Matar C (2018) The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 10(11):1618

Article  PubMed  PubMed Central